At a glance
- Originator Taiyo
- Class Nootropics
- Mechanism of Action Calcium channel antagonists; Potassium channel antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Cerebrovascular disorders
Most Recent Events
- 19 Dec 1996 No-Development-Reported for Cerebrovascular disorders in Japan (Unknown route)